Hemopexin: a review of biological aspects and the role in laboratory medicine.

[1]  L. Kühn.  Iron and gene expression: molecular mechanisms regulating cellular iron homeostasis. , 2009, Nutrition reviews.

[2]  M. Buyzere,et al.  A new Method for Fast Haptoglobin Phenotyping and Hemoglobin Binding Capacity Calculation Based on Capillary Zone Electrophoresis , 2000, Clinical chemistry and laboratory medicine.

[3]  B. Pipy,et al.  Respective roles of inflammation and axonal breakdown in the regulation of peripheral nerve hemopexin: an analysis in rats and in C57BL/Wlds mice , 2000, Journal of Neuroimmunology.

[4]  J. Delanghe,et al.  Reference range of serum haptoglobin is haptoglobin phenotype-dependent in blacks. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[5]  J. Baller,et al.  Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. , 2000, Kidney international.

[6]  Ann Smith,et al.  Heme Binding by Hemopexin: Evidence for Multiple Modes of Binding and Functional Implications , 2000, Journal of protein chemistry.

[7]  L. Silengo,et al.  Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. , 1999, Blood.

[8]  Edward N. Baker,et al.  Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two β-propeller domains , 1999, Nature Structural Biology.

[9]  T. Borghuis,et al.  Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. , 1999, Journal of the American Society of Nephrology : JASN.

[10]  N. Shaklai,et al.  Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. , 1999, Biochimica et biophysica acta.

[11]  P. O'Brien,et al.  The effects of heme-binding proteins on the peroxidative and catalatic activities of hemin. , 1999, Free radical biology & medicine.

[12]  W. Bode,et al.  Structural properties of matrix metalloproteinases , 1999, Cellular and Molecular Life Sciences CMLS.

[13]  C. Overall,et al.  Identification of the Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Binding Site on the Hemopexin Carboxyl Domain of Human Gelatinase A by Site-directed Mutagenesis , 1999, The Journal of Biological Chemistry.

[14]  N. Bertrand,et al.  Regulation of Hemopexin Synthesis in Degenerating and Regenerating Rat Sciatic Nerve , 1999, Journal of neurochemistry.

[15]  Ann Smith,et al.  Cellular Protection Mechanisms against Extracellular Heme , 1999, The Journal of Biological Chemistry.

[16]  L. Kotra,et al.  Matrix metalloproteinases: structures, evolution, and diversification , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  E. Hansen,et al.  Binding of Heme-Hemopexin Complexes by Soluble HxuA Protein Allows Utilization of This Complexed Heme byHaemophilus influenzae , 1998, Infection and Immunity.

[18]  S. Immenschuh,et al.  Hemopexin decreases spontaneous chemiluminescence of cold preserved liver after reperfusion. , 1998, Biochemical and biophysical research communications.

[19]  K. Dutt,et al.  Expression of the protective proteins hemopexin and haptoglobin by cells of the neural retina. , 1998, Experimental eye research.

[20]  M. D. De Buyzere,et al.  Congenital anhaptoglobinemia versus acquired hypohaptoglobinemia. , 1998, Blood.

[21]  E. Hurt-Camejo,et al.  Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. , 1998, Journal of lipid research.

[22]  Ann Smith,et al.  Coordination of Nitric Oxide by Heme—Hemopexin , 1998, Journal of protein chemistry.

[23]  P. Whitby,et al.  Transcription of genes encoding iron and heme acquisition proteins of Haemophilus influenzae during acute otitis media , 1997, Infection and immunity.

[24]  K. Kuželová,et al.  Kinetics of heme interaction with heme-binding proteins: the effect of heme aggregation state. , 1997, Biochimica et biophysica acta.

[25]  R. Hunt,et al.  Role of heme-hemopexin in human T-lymphocyte proliferation. , 1997, Experimental cell research.

[26]  C. Overall,et al.  The Hemopexin-like Domain (C Domain) of Human Gelatinase A (Matrix Metalloproteinase-2) Requires Ca2+ for Fibronectin and Heparin Binding , 1997, The Journal of Biological Chemistry.

[27]  G. Murphy,et al.  Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[28]  H. Meltzer,et al.  Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs , 1997, Psychiatry Research.

[29]  Ann Smith,et al.  Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. , 1996, Biochemistry.

[30]  J. Delanghe,et al.  Biological and clinical significance of haptoglobin polymorphism in humans. , 1996, Clinical chemistry.

[31]  M. Hentze,et al.  Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Ann Smith,et al.  Heme‐mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin , 1996, Journal of cellular physiology.

[33]  Ann Smith,et al.  Hemopexin in the human retina: Protection of the retina against heme‐mediated toxicity , 1996, Journal of cellular physiology.

[34]  M. Maines,et al.  Renal ischemia/reperfusion up-regulates heme oxygenase-1 (HSP32) expression and increases cGMP in rat heart. , 1996, The Journal of pharmacology and experimental therapeutics.

[35]  R. Stern,et al.  Hyaluronan‐binding properties of human serum hemopexin , 1996, FEBS letters.

[36]  W. Bode,et al.  The C‐terminal (haemopexin‐like) domain structure of human gelatinase A (MMP2): structural implications for its function , 1996, FEBS letters.

[37]  J. Gutteridge,et al.  Lipid peroxidation and antioxidants as biomarkers of tissue damage. , 1995, Clinical chemistry.

[38]  G. Chatellier,et al.  Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins. , 1995, Parasite.

[39]  A. Fontanellas,et al.  Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda. , 1995, The international journal of biochemistry & cell biology.

[40]  V. Drossou,et al.  Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. , 1995, Clinical chemistry.

[41]  U. Muller-eberhard,et al.  The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness. , 1995, Biochemical and biophysical research communications.

[42]  H. Jacob.  Newly recognized causes of atherosclerosis: the role of microorganisms and of vascular iron overload. , 1994, The Journal of laboratory and clinical medicine.

[43]  H. Baumann,et al.  The rat and human hemopexin genes contain an identical interleukin-6 response element that is not a target of CAAT enhancer-binding protein isoforms. , 1994, The Journal of biological chemistry.

[44]  J. Eaton,et al.  Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Bunker,et al.  Hemopexin: a unique genetic polymorphism in populations of African ancestry. , 1993, Human biology.

[46]  R. Klausner,et al.  Regulating the fate of mRNA: The control of cellular iron metabolism , 1993, Cell.

[47]  E. Pesci,et al.  Iron acquisition and hemolysin production by Campylobacter jejuni , 1992, Infection and immunity.

[48]  P. Ferrara,et al.  Hemopexin is synthesized in peripheral nerves but not in central nervous system and accumulates after axotomy. , 1992, The Journal of biological chemistry.

[49]  I. Tabbara,et al.  Hemolytic anemias. Diagnosis and management. , 1992, The Medical clinics of North America.

[50]  J. Alam,et al.  Heme-hemopexin-mediated induction of metallothionein gene expression. , 1992, The Journal of biological chemistry.

[51]  M. Miwa,et al.  Changes in 40 serum proteins of post-menopausal women. , 1991, Maturitas.

[52]  J. Gitlin,et al.  Rat hemopexin. Molecular cloning, primary structural characterization, and analysis of gene expression. , 1991, Biochemistry.

[53]  R. Hunt,et al.  Hemopexin joins transferrin as representative members of a distinct class of receptor-mediated endocytic transport systems. , 1990, European journal of cell biology.

[54]  R. Lauwerys,et al.  Urinary proteins and red blood cell membrane negative charges in diabetes mellitus. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[55]  H. Kohno,et al.  Hemopexin-dependent down-regulation of expression of the human transferrin receptor. , 1990, The Journal of biological chemistry.

[56]  J. Alam,et al.  Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells. , 1989, The Journal of biological chemistry.

[57]  U. Muller-eberhard,et al.  Serum proteins as mediators of hemin efflux from red cell membranes: specificity of hemopexin , 1989, FEBS letters.

[58]  H. Kohno,et al.  The hemopexin receptor on the cell surface of human polymorphonuclear leukocytes. , 1989, Cell structure and function.

[59]  J. Gutteridge,et al.  Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. , 1988, The Biochemical journal.

[60]  C. Jones,et al.  The hemopexin gene maps to the same location as the β-globin gene cluster on human chromosome 11 , 1988 .

[61]  T. P. Conway,et al.  Use of hemopexin domains and monoclonal antibodies to hemopexin to probe the molecular determinants of hemopexin-mediated heme transport. , 1988, The Journal of biological chemistry.

[62]  D. Wojciechowicz,et al.  A turbidometric assay for measuring proteins in culture media. , 1988, Journal of immunological methods.

[63]  R. Ferrell,et al.  Genetic studies of low-abundance human plasma proteins. VI. Polymorphism of hemopexin. , 1987, American journal of human genetics.

[64]  S. Naylor,et al.  Hemopexin is localized to human chromosome 11 , 1987, Somatic cell and molecular genetics.

[65]  H. Kohno,et al.  Isolation of the hemopexin receptor from human placenta. , 1987, The Journal of biological chemistry.

[66]  T. Prior,et al.  Carrier detection in Duchenne muscular dystrophy: a review of current issues and approaches. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[67]  L. Morávek,et al.  Amino acid sequence of the N‐terminal region of human hemopexin , 1984, FEBS letters.

[68]  M. Percy,et al.  Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination. , 1984, American journal of medical genetics.

[69]  W. Engel,et al.  Hemopexin metabolism in patients with altered serum levels. , 1983, The Journal of laboratory and clinical medicine.

[70]  A. Smith,et al.  Haematoporphyrin and OO'-diacetylhaematoporphyrin binding by serum and cellular proteins. Implications for the clearance of these photochemotherapeutic agents by cells. , 1983, The Biochemical journal.

[71]  J. Lizana,et al.  Immunonephelometry of specific proteins in human seminal plasma. , 1983, Clinical chemistry.

[72]  M. W. Thompson,et al.  Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination. , 1982, American journal of medical genetics.

[73]  J. Tutor,et al.  Serum copper concentration and hepatic enzyme induction during long-term therapy with anticonvulsants. , 1982, Clinical chemistry.

[74]  W. Morgan,et al.  Hemopexin-mediated transport of heme into isolated rat hepatocytes. , 1981, The Journal of biological chemistry.

[75]  U. Muller-eberhard,et al.  The interaction of heme-hemopexin with CO. , 1981, The Journal of biological chemistry.

[76]  A. Vladutiu,et al.  Absence of beta-globulin band in the serum protein electropherogram of a patient with liver disease. , 1981, Clinical chemistry.

[77]  A. Smith,et al.  Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein. , 1979, The Biochemical journal.

[78]  W. Engel,et al.  Elevations of hemopexin levels in neuromuscular disease. , 1978, Archives of neurology.

[79]  W. Engel,et al.  Depletion of serum hemopexin in fulminant rhabdomyolysis. Evidence for an interaction of hemopexin with myoglobin-derived heme. , 1978, Archives of neurology.

[80]  R. C. Coombes,et al.  Tumour Markers , 1977 .

[81]  J. Keul,et al.  [Changes in serum proteins,-iron and -copper in swimmers before and after altitude training (author's transl)]. , 1976, European journal of applied physiology and occupational physiology.

[82]  U. Muller-eberhard,et al.  Sites of formation of the serum proteins transferrin and hemopexin. , 1973, The Journal of clinical investigation.

[83]  B. Allinquant,et al.  [Electro-immunodiffusion of cerebrospinal fluid proteins. Determination of 2 -HS, ceruloplasmin, - 1A - 1C , hemopexin and IgA]. , 1971, Clinica chimica acta; international journal of clinical chemistry.

[84]  J. Sonneck,et al.  Serum haemopexin levels in patients with malignant melanoma. , 1971, Clinica chimica acta; international journal of clinical chemistry.

[85]  W. Pryse-Phillips,et al.  SERUM PROTEINS IN NORMAL PREGNANCY AND MILD PRE‐ECLAMPSIA , 1971, The Journal of obstetrics and gynaecology of the British Commonwealth.

[86]  I. Beswick,et al.  THE ARIAS‐STELLA PHENOMENON AND THE DIAGNOSIS OF PREGNANCY , 1971, The Journal of obstetrics and gynaecology of the British Commonwealth.

[87]  J. Studd,et al.  SERUM PROTEIN CHANGES IN THE PRE‐ECLAMPSIA‐ECLAMPSIA SYNDROME , 1970, The Journal of obstetrics and gynaecology of the British Commonwealth.

[88]  U. Muller-eberhard,et al.  Assessment of Rh disease by ratios of bilirubin to albumin and hemopexin to albumin in amniotic fluid. , 1970, The New England journal of medicine.

[89]  F. Oski,et al.  PLASMA HEMOPEXIN AND HAPTOGLOBIN IN HEMOLYTIC DISEASES OF THE NEWBORN , 1970, Acta paediatrica Scandinavica.

[90]  D. Sears.  Depletion of Plasma Hemopexin in Man by Hematin Injections∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[91]  U. Muller-eberhard,et al.  Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. , 1968, Blood.

[92]  H. Bunn,et al.  Exchange of heme among hemoglobins and between hemoglobin and albumin. , 1968, The Journal of biological chemistry.

[93]  L. Garby,et al.  Studies on hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man. , 1959, The Journal of clinical investigation.

[94]  L. Garby,et al.  Studies on hemoglobin metabolism. II. Pathways of hemoglobin iron metabolism in normal man. , 1959, Journal of Clinical Investigation.

[95]  C. Burtis.  Tietz textbook of Clinical Chemistry , 1994 .

[96]  J. Eaton,et al.  Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endothelium. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[97]  R. Tenhunen.  Heme in the treatment of heme deficiency states. , 1990, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[98]  A. Gressner,et al.  Immunonephelometric Quantification of Free Haemoglobin , 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[99]  Y. Takahashi,et al.  Complete amino acid sequence of human hemopexin, the heme-binding protein of serum. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[100]  U. Muller-eberhard,et al.  A radioimmunoassay employing polyethylene glycol (PEG) for measuring dilute concentrations of rat hemopexin, albumin and haptoglobin. , 1975, Immunochemistry.